Waters Corp (WAT)
341.59
+1.93 (+0.57%)
USD |
NYSE |
Jul 06, 10:17
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 20.58B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | -4.45% |
| Valuation | |
| PE Ratio | 29.89 |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 7.336 |
| Price to Book Value | 54.88 |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | 3.852 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 35.86% |
News
Headline
Wire
Time (ET)
MT Newswires
07/05 10:50
Yahoo
06/20 19:00
Yahoo
06/20 11:19
SA Breaking News
06/14 10:29
Yahoo
06/09 10:59
Yahoo
06/06 08:00
Events
| DATE | TIME | TYPE | PERIOD | REPORTED EPS |
ESTIMATED EPS |
SURPRISE | |
| 08/03/2022* | -- | Results | Q2 2022 | -- | 2.66 | -- | |
| 08/03/2022* | 08:00 EST | Earnings Call | Q2 2022 | -- | -- | -- | |
| 05/03/2022 | -- | Results | Q1 2022 | 2.80 | 2.34 | 19.79% | |
| 05/03/2022 | 08:00 EST | Earnings Call | Q1 2022 | -- | -- | -- | |
| 02/01/2022 | -- | Results | Q4 2021 | 3.67 | 3.49 | 5.29% | |
| 02/01/2022 | 08:00 EST | Earnings Call | Q4 2021 | -- | -- | -- | |
| 11/02/2021 | -- | Results | Q3 2021 | 2.66 | 2.36 | 12.70% | |
| 11/02/2021 | 08:00 EST | Earnings Call | Q3 2021 | -- | -- | -- |
*Estimated Date/Time
Earnings
Profile
Edit
| Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2020, Waters generated 59% from pharmaceutical customers, 30% from industrial clients, and 11% from academic/government institutions. |
| URL | https://www.waters.com |
| Investor Relations URL | https://www.waters.com/waters/en_US/Investors/nav.htm?cid=134614445&locale=en_US |
| HQ State/Province | Massachusetts |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Equity Style | Mid Cap/Blend |
| Next Earnings Release | Aug. 03, 2022 (est.) |
| Last Earnings Release | May. 03, 2022 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Nov. 26, 1996 |
Analyst Coverage
|
Consensus Rating
|
|
|
Analyst Recommendation
|
|
Source: S&P Global
Dividends
| Dividend Per Share (TTM) | 0.00 |
|
2017
2018
2019
2020
2021
6.00%
4.00%
2.00%
|
|
| Yield to Market | -- |
| Yield to Sector | -- |
| Yield to Industry | -- |
| Last Dividend Amt. | -- |
| Dividend Frequency | -- |
| Last Ex-Dividend Date | Nov. 26, 1996 |
| Yield (TTM) | 0% |
| Forward Yield | -- |
| Payout Ratio | 0.00% |
| Cash Payout Ratio | 0.00% |
| Consistent Payer (5Y) | No |
| Consistent Growth (5Y) | No |
Risk Info
Total Returns Comparison
Annual Total Returns Versus Peers
As of July 05, 2022.
Fundamentals
| Revenue (TTM) | 2.868B |
| Total Expenses (TTM) | 2.007B |
| Net Income (TTM) | 704.55M |
| Total Assets (Quarterly) | 3.041B |
| Total Liabilities (Quarterly) | 2.666B |
| Shareholders Equity (Quarterly) | 374.94M |
| Cash from Operations (TTM) | 726.83M |
| Cash from Investing (TTM) | -53.63M |
| Cash from Financing (TTM) | -854.46M |
Ratings
Profile
Edit
| Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2020, Waters generated 59% from pharmaceutical customers, 30% from industrial clients, and 11% from academic/government institutions. |
| URL | https://www.waters.com |
| Investor Relations URL | https://www.waters.com/waters/en_US/Investors/nav.htm?cid=134614445&locale=en_US |
| HQ State/Province | Massachusetts |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Equity Style | Mid Cap/Blend |
| Next Earnings Release | Aug. 03, 2022 (est.) |
| Last Earnings Release | May. 03, 2022 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Nov. 26, 1996 |
Risk Info
Ownership
| Insider Ownership Percentage | Upgrade |
Jul '20
Nov '20
Mar '21
80.00%
40.00%
10.00%
Analyst Coverage
|
Consensus Rating
|
|
|
Analyst Recommendation
|
|
Source: S&P Global
Top Fund Holders
| Symbol | Dollars Invested | % Weight |
|---|---|---|
| PHO | 67.89M USD | 4.34% |
| MAW108 | 116.24M USD | 2.48% |
| CIPMX | 164.51M USD | 2.44% |
| NWT088 | 29.29M USD | 2.26% |
| PXEAX | 53.91M USD | 2.26% |
| IBB | 159.47M USD | 2.05% |
| ATL774 | 49.01M USD | 2.04% |
| IHI | 126.49M USD | 1.91% |
| RYH | 13.88M USD | 1.59% |
| PDP | 13.62M USD | 1.29% |
| SUSA | 37.82M USD | 1.16% |
| BBGSX | 38.36M USD | 0.68% |
Other Resources
| Whale Wisdom | 13F Filings |
| Seeking Alpha | Call Transcripts |
| Morningstar | Insider Trading |
| Nasdaq | Institutional Ownership |
| Nasdaq | Option Chain |
| SEC | SEC Filings |
| WAT Tweets |